Report a problem

28.6m / 27.6m

More Details..

	OR

Email Id:	(Required) (Required)
Password:	*(Required)
	Remember Me	Reset Password?
	Note: Please enter emailid to receive instructions to reset password.

	Not A Member Yet ? Sign Up

Email Id:	(Required) (Required)
Password:	*(Required)
	Remember Me	Reset Password?
	Note: Please enter emailid to receive instructions to reset password.

Name	*(Required)
Email	*(Required)
Telephone	(Required) (Invalid number !)
Subject	*(Required)
Comment	*(Required)


	Send

Runjhun Jain

Nirmal Bang Securities

Bulls Eye

Runjhun Jain

17 Jan 2017

Runjhun Jain

Linkedin:

Research Reports :

Paradeep Phosph
17 May 22

IPO

Paradeep Phosphates Ltd (PPL) is the second largest private sector manufacturer of non-urea fertilizers in India

Nirmal Bang Securities

Indigo Paint
20 Jan 21

IPO Note

Given the sound management and strong growth prospects, we recommend “Subscribe”.

Nirmal Bang Securities

Chemcon Speciality Target: Rs 340.00
21 Sep 20

IPO Note

Chemcon Specialty Chemicals Ltd (Chemcon) is a manufacturer of specialised chemicals,

Nirmal Bang Securities

Rossari
13 Jul 20

IPO Note

Rossari Biotech Ltd (Rossari) is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of the customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified

More..

Nirmal Bang Securities

Vaibhav Global Target: Rs 608.00
29 May 17

Result Update

Vaibhav Global Ltd (VGL) continued the recovery during the quarter as well and

Nirmal Bang Securities

Balaji Amines Target: Rs 485.00
16 May 17

Result Update

Balaji Amines Limited (BAL), set up in 1988, is a leading manufacturer of Aliphatic Amines

Nirmal Bang Securities

Alembic Pharma Target: Rs 632.00
16 May 17

Result Update

Subdued Results; growth one more year away

Nirmal Bang Securities

Granules India Target: Rs 167.00
16 May 17

Result Update

Granules India’s reported flat results for the year FY17 and marginal dip for Q4

Nirmal Bang Securities

Alembic Pharma Target: Rs 632.00
05 May 17

Result Update

Alembic Pharma Limited (APL) results were marginally below expectations due to muted growth both in domestic and international businesses.

Nirmal Bang Securities

Sintex
07 Apr 17

Demerger only RBI approval is pending for FCCB which managment expects to get in next 15 days. Post that Record date will be announce and stock will go out of F&O on record date.

Nirmal Bang Securities

Dr Lal PathLab Target: Rs 20.00
05 Apr 17

Company Update

Organised players eating up unorganised market share:

Nirmal Bang Securities

Avenue Supermarts
07 Mar 17

IPO Note

The whole issue of Rs 1870 cr (at upper price) is fresh issue which would be utilized to repay the debt (Rs 1080cr), capex (Rs 366 cr) and for corporate purposes.

Nirmal Bang Securities

Vaibhav Global Target: Rs 553.00
10 Feb 17

Result Update

TV sales witnessed volume growth of 15% vs 5% seen in Q2FY17. Web sales saw positive volume growth of 10% after eight quarters of decline

Nirmal Bang Securities

Granules India Target: Rs 151.00
09 Feb 17

Results Update

Granules India’s results were broadly in-line with expectations Sales grew by 10.6% yoy to Rs 360 cr.

Nirmal Bang Securities

Vaibhav Global Target: Rs 353.00
26 Dec 16

Company Update

VGL had revised its average selling price to its previous levels of $23 on TV sales (had increased for quarters to $27-28) as repeat purchase and retention rate are better at this price.

Nirmal Bang Securities